Fig. 1 · Structure
Documents & Downloads
GEMSA
Enkephalin Convertase Inhibitor
GEMSA is a potent inhibitor of enkephalin convertase, with a Ki value of 8.8 nM. By inhibiting this enzyme, GEMSA contributes to analgesic effects, making it a valuable tool in pain research. Its role in modulating opioid peptide metabolism highlights its potential applications in studying pain pathways and developing analgesic therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 77482-44-1 |
| Applications | Enkephalin Convertase Inhibitor |
| Formula | C7H13N3O4S |
| Molecular Weight | 235.26 |
| Synonyms | 2-Guanidinoethylmercaptosuccinic acid |
| SMILES | OC(C(SCCNC(N)=N)CC(O)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.